Alyeska Investment Group’s Omega Healthcare OHI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q3
Sell
-2,090,618
Closed -$76.6M 684
2025
Q2
$76.6M Buy
+2,090,618
New +$77.6M 0.27% 110
2024
Q4
Sell
-532,086
Closed -$21.7M 638
2024
Q3
$21.7M Buy
532,086
+429,250
+417% +$16.2M 0.11% 232
2024
Q2
$3.52M Buy
+102,836
New +$3.24M 0.02% 368
2023
Q4
Sell
-314,306
Closed -$10.4M 623
2023
Q3
$10.4M Sell
314,306
-87,773
-22% -$2.8M 0.07% 276
2023
Q2
$12.3M Sell
402,079
-651,525
-62% -$18.8M 0.09% 247
2023
Q1
$28.9M Buy
+1,053,604
New +$29.3M 0.25% 119
2022
Q3
Sell
-167,842
Closed -$4.73M 452
2022
Q2
$4.73M Buy
+167,842
New +$4.78M 0.05% 300

Other funds holding OHI

Alyeska Investment Group's OHI Position: Q3 2025 in Review

Alyeska Investment Group sold out of Omega Healthcare (OHI) in Q3 2025, closing a stake of 2,090,618 shares — an estimated $76.6M sold.

Alyeska Investment Group first reported a position in OHI in Q2 2022 and held it in 7 quarters. The position peaked at $76.6M in Q2 2025. 681 funds tracked by Wall St. Rank hold OHI as of Q3 2025.

  • Alyeska Investment Group reported no remaining Omega Healthcare position as of Q3 2025 after selling out during the quarter.
  • Alyeska Investment Group sold 2,090,618 Omega Healthcare shares in Q3 2025, an estimated $76.6M.
  • Alyeska Investment Group first reported a position in Omega Healthcare in Q2 2022 and held it in 7 quarters.
  • Alyeska Investment Group's Omega Healthcare position peaked at $76.6M in Q2 2025.
  • 681 funds tracked by Wall St. Rank held Omega Healthcare as of Q3 2025.

Based on Alyeska Investment Group's 13F filing for Q3 2025, filed 17 Nov 2025.